Sonova (OTCMKTS:SONVY) Stock Price Passes Above 50-Day Moving Average – Here’s Why

Shares of Sonova Holding (OTCMKTS:SONVYGet Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $46.75 and traded as high as $47.08. Sonova shares last traded at $46.09, with a volume of 52,866 shares trading hands.

Analyst Ratings Changes

SONVY has been the subject of several recent analyst reports. Zacks Research upgraded Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. BNP Paribas Exane upgraded Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Finally, Jefferies Financial Group lowered Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Get Our Latest Stock Analysis on Sonova

Sonova Price Performance

The firm has a 50 day simple moving average of $46.75 and a 200-day simple moving average of $50.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 1.24.

About Sonova

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Featured Stories

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.